» Articles » PMID: 28368947

Female Reproductive Factors, Exogenous Hormone Use, and Pancreatic Cancer Risk: the Japan Public Health Center-based Prospective Study

Overview
Specialty Oncology
Date 2017 Apr 4
PMID 28368947
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

An association between female reproductive factors, exogenous hormone use, and pancreatic cancer risk has long been suggested in laboratory settings, but epidemiological findings remain mixed and inconclusive. Studies carried out on Asian populations are also limited. In this study, 45 617 women aged 40-69 years were followed for an average of 18.4 years in the Japan Public Health Center-based prospective cohort and 211 pancreatic cases were identified as of 31 December 2011. We applied multivariate-adjusted Cox proportional hazards regression models using age as a time-scale to assess the association between female reproductive factors (menstrual status, menarche age, menopause age, number of births, age at first birth, total years of fertility, history of breastfeeding) and exogenous hormone use with the incidence of pancreatic cancer through hazard ratios and confidence intervals. No significant associations were found between our examined female reproductive factors and pancreatic cancer incidence. The use of exogenous hormones was found to be associated with an increased risk of pancreatic cancer in a multivariate-adjusted model (hazard ratio: 1.47; 95%; confidence interval: 1.00-2.14) in the Japanese female population. Our results suggest that exogenous hormones may play a role in the formation of pancreatic cancer, and further prospective studies are warranted for clarification.

Citing Articles

Distribution, Risk Factors and Epidemiological Trends of Pancreatic Cancer Across Countries' Income Levels: A Comprehensive Analysis.

Wik S, Tian W, Zhong C, Sawhney A, Gao M, Yu Q Cancer Rep (Hoboken). 2025; 8(2):e70154.

PMID: 39957387 PMC: 11830997. DOI: 10.1002/cnr2.70154.


Hormone replacement therapy and risk of pancreatic cancer in postmenopausal women: Evidence from the US National Inpatient Sample 2008-2018.

Liu L, Wang X, Guo D, Ma R, Gong H, Wang C Heliyon. 2024; 10(18):e37588.

PMID: 39309886 PMC: 11415697. DOI: 10.1016/j.heliyon.2024.e37588.


The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocrine Tumors: A Nationwide Time-Trend Analysis Using 2001-2018 United States Cancer Statistics Databases.

Jiang Y, Abboud Y, Liang J, Larson B, Osipov A, Gong J Cancers (Basel). 2024; 16(5).

PMID: 38473332 PMC: 10931165. DOI: 10.3390/cancers16050971.


Adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and risk of 14 lifestyle-related cancers in the UK Biobank prospective cohort study.

Malcomson F, Parra-Soto S, Ho F, Lu L, Celis-Morales C, Sharp L BMC Med. 2023; 21(1):407.

PMID: 38012714 PMC: 10683228. DOI: 10.1186/s12916-023-03107-y.


Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women.

Peduzzi G, Archibugi L, Katzke V, Gentiluomo M, Capurso G, Milanetto A Sci Rep. 2022; 12(1):18100.

PMID: 36302831 PMC: 9613634. DOI: 10.1038/s41598-022-22973-9.